Neoprobe gets grant to further Lymphoseek development

11/3/2010 | MarketWatch

Neoprobe has received a nearly $250,000 grant from the qualifying therapeutic discovery project program, which was developed under the health reform law. "This cash award will provide additional support for the development of Lymphoseek, our lead program, without diluting the value of either our assets or our equity," President and CEO David C. Bupp said.

View Full Article in:

MarketWatch

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC